OGEN — Oragenics Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Oragenics Inc

Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene ampli… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$0.59
Market Cap$2.6M
Float4.2M
Shares Outstanding4.5M
Price/Sales (TTM)89.28
vs. Analyst Target+239.0% to analyst PT
Dividend RateNone
Analyst Target Price$2.00 (1 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$26.4M -$22.1M -$26.6M
2021 $86,987 -$15.7M $45,750 -$15.7M
2022 $131,521 -$14.3M $86,854 -$14.2M
2023 $37,653 -$20.7M -$27,391 -$20.6M
2024 N/A -$10.6M -$4.1M -$10.5M
2025 N/A -$9.8M N/A -$9.4M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$2.3M
Sep 2025 N/A -$3.1M
Dec 2025 N/A -$2.3M
Mar 2026 N/A -$2.2M

Ownership & Float

Insider Ownership2.0%
Institutional Ownership6.7%
Short Float16.6%
% of All Funds Holding0.22%
Number of Funds Holding18

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$0.65Near-term / short-term trend
Weekly40-Week SMA$0.92Medium-term trend
Weekly80-Week SMA$3.84Cyclical trend (business cycle)
Weekly200-Week SMA$98.04Secular trend (multi-year)
Monthly10-Month SMA$0.86Near-term monthly trend
Monthly20-Month SMA$3.87Medium-term monthly trend
Monthly40-Month SMA$41.12Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$1.70 resistance 5.04x 9 months ago
$36.90 resistance 1.66x 19 months ago

Historical Earnings Reactions (85 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.45% 0.00% 29.41% 12.50% -25.58%
1 Day -0.48% 0.00% 30.59% 48.57% -16.67%
1 Week -1.18% -3.39% 34.12% 54.35% -27.91%
2 Weeks -3.37% -4.76% 32.94% 66.67% -34.88%
1 Month -4.10% -7.78% 31.76% 119.17% -64.29%

Next earnings: May 8, 2026

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan10.1%50.0%22
Feb4.9%40.9%22
Mar-15.4%17.4%23
Apr-4.7%34.8%23
May2.8%45.5%22
Jun8.7%54.5%22
Jul5.7%54.5%22
Aug-9.5%13.6%22
Sep-0.8%27.3%22
Oct-6.6%31.8%22
Nov6.8%50.0%22
Dec-11.6%27.3%22

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.01% 34.6% 1047
Tuesday 0.13% 35.4% 1147
Wednesday -0.10% 34.5% 1147
Thursday -0.33% 34.4% 1126
Friday 0.74% 37.2% 1120

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 6.7%

Insider Transactions — Smart Summary

Total insider ownership: 2.0%

12-Month Insider Activity Summary

Total Filings4
Net Value+N/A
Net Shares Change-17,464
% of Float-0.4%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Odyssey Health, Inc. -$74,007.539 2 2 sell
Telling Fred -$396.732 2 2 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-01-22 Telling Fred -$198.366 Transaction at $0.94, now -37.5%
2025-12-15 Telling Fred -$198.366 Transaction at $0.94, now -37.5%
2025-06-16 Odyssey Health, Inc. -$43,600 Transaction at $4.36, now -86.5%
2025-06-18 Odyssey Health, Inc. -$30,407.539 Transaction at $4.32, now -86.3%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Oragenics Inc (OGEN) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for OGEN on Trend Edge →